后COVID-19和刺激性肠综合征:文学综述
Daniel Paramythiotis1, Eleni Karlafti2,3, Matthaios Didagelos4
1First Propaedeutic Department of Surgery, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Medicina (Kaunas, Lithuania)
|November 25, 2023
概括
后COVID-19综合征 (PCS) 包括胃肠道问题,如刺激性肠综合征 (IBS). 本综述探讨了COVID-19感染如何导致感染后IBS (PI-IBS),这是一个日益严重的全球健康问题.
科学领域:
- 胃肠病学和传染病学
- 肠-大脑轴研究研究
- 长期健康结果
背景情况:
- 后COVID-19综合征 (PCS) 涵盖了SARS-CoV-2感染后的各种症状.
- 刺激性肠综合征 (IBS) 是一种普遍存在的慢性胃肠道疾病,影响生活质量.
- 胃肠道表现,包括IBS类症状,是PCS的公认组成部分.
研究的目的:
- 审查PCS中的胃肠道参与.
- 探索感染后IBS (PI-IBS) 在有COVID-19病史的人群中的潜在发展.
- 了解COVID-19对肠道健康的长期影响.
主要方法:
- 关于病理生理机制的文献综述.
- 对PCS内IBS患病率的流行病学研究的分析.
- 综合有关COVID-19后PI-IBS发展的当前知识.
主要成果:
- COVID-19 感染可以引发或加剧胃肠道功能障碍.
- 肠道感染,压力和抗生素等因素可能导致PI-IBS的发展.
- 目前关于PI-IBS的研究有限,突出了知识缺口.
结论:
- COVID-19 构成发展PI-IBS的风险,这是一个重大的长期健康挑战.
- 了解PI-IBS病原体对于开发向治疗至关重要.
- 需要进一步的研究来解决PI-IBS日益增长的流行和管理问题.
相关概念视频
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
165
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
165
Irritable Bowel Syndrome I: Introduction
280
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
280
Irritable Bowel Syndrome III: Medical and Nursing Management
212
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
212
Chronic Bowel Disorders: Introduction
456
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
456
Drugs for Treatment of Diarrhea-Predominant IBS
182
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
182
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
335
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335


